Physician profile
Etan Orgel
NPI 1750548632
$27,097.14
in general payments reported to CMS, 2019-2025
5 companies · $5,748 in 2025
The $5,748 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,075 · 2021: $2,434 · 2022: $3,410 · 2023: $6,300 · 2024: $4,130 · 2025: $5,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,348 · Travel and Lodging: $378 · Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,162.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,348.00 |
| Travel and Lodging | $378.38 |
| Food and Beverage | $289.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $19,025.86 | 2021-2025 | Rylaze, Defitelio |
| Servier Pharmaceuticals LLC | $5,074.78 | 2019 | |
| Syndax Pharmaceuticals, INC. | $1,868.31 | 2025 | Revuforj |
| Seagen INC. | $1,100.00 | 2022 | |
| Shorla Oncology INC. | $28.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Etan Orgel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.